Cancer Research Targets  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 9041, November 1, 2008. doi: 10.1158/0008-5472.CAN-08-2632
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, C. S.
Right arrow Articles by Song, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C. S.
Right arrow Articles by Song, J. S.

Systems Biology and Emerging Technologies

CCCTC-Binding Factor Confines the Distal Action of Estrogen Receptor

Chang S. Chan and Jun S. Song

The Simons Center for Systems Biology, Institute for Advanced Study, Princeton, New Jersey

Requests for reprints: Jun S. Song, The Simons Center for Systems Biology, Institute for Advanced Study, Einstein Drive, Princeton, NJ 08540. Phone: 609-734-8038; Fax: 609-951-4438; E-mail: jssong{at}ias.edu.

Key Words: CTCF • estrogen receptor • Bayesian belief network

Distal enhancers have recently emerged as a common mode of gene regulation for several transcription factors, including estrogen and androgen receptors, the two key regulators of breast and prostate cancer major subtypes. Despite the rapid success in genome-wide annotation of estrogen receptor-{alpha} (ER{alpha}) binding sites in cell lines, the precise mechanism governing the gene-to-enhancer association is still unknown and no quantitative model that can predict the estrogen responsiveness of genes has been hitherto proposed. This article presents an integrative genomics approach to construct a predictive model that can explain more than 70% of estrogen-induced expression profiles. The proposed method combines a recent map of the insulator protein CCCTC-binding factor (CTCF) with previous ER location studies and expression profiling in the presence of the translation inhibitor cycloheximide, providing evidence that CTCF partitions the human genome into distinct ER-regulatory blocks. It is shown that estrogen-responsive genes with a decreased transcription level (down-regulated genes) have a markedly different relative distribution of ER binding sites compared with those with an increased transcription level (up-regulated genes). Finally, Bayesian belief networks are constructed to quantify the effects of ER-binding distance from genes as well as the insulating effects of CTCF on the estrogen responsiveness of genes. This work thus represents a stride toward understanding and predicting the distal activities of steroid hormone nuclear receptors. [Cancer Res 2008;68(21):9041–9]




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
M. Lupien and M. Brown
Cistromics of hormone-dependent cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 381 - 389.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
J. W. Pike, M. B. Meyer, and M. L. Martowicz
New Techniques in Transcription Research Extend Our Understanding of the Molecular Actions of the Vitamin D Hormone
IBMS BoneKEy, May 1, 2009; 6(5): 169 - 180.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. Eeckhoute, M. Lupien, C. A. Meyer, M. P. Verzi, R. A. Shivdasani, X. S. Liu, and M. Brown
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Genome Res., March 1, 2009; 19(3): 372 - 380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.